Medical Oncology

The medical oncology department primarily treats cancer using drugs. These treatments can be curative, or to alleviate symptoms to make the illness more bearable. 

What can we do for you?

We strive to increase the odds of recovery or longer life using combination treatments. 

  • We offer treatment with chemotherapy, targeted therapy, and hormone therapy. These treatments are usually given in combination with surgery or radiation. For all treatments with drugs, your medical oncologist will be your practicing physician and contact point. 
  • Our medical oncologists conduct research into cancer drugs. Sometimes this involves drugs that have never been given to people before, or medication that is compared to the standard treatment in a large-scale trial. 
Our team

Treatment with cancer drugs is usually given in combination with surgery or radiation. Medical oncologists closely collaborate with a multidisciplinary team. 

We are here for...

  • Patients with a type of cancer that can be cured with drugs.
  • Patients who opt for treatment as part of a clinical trial instead of the standard treatment. 
  • Patients who no longer have standard treatment available to them, and who want to take part in a clinical pharmacological trial. 
  • Patients with rare metastatic tumors.
  • Patients with secondary cancers (cancer that occurs as a result of treatment for primary cancer).
  • Patients who choose treatment delivered in collaboration with nuclear medicine specialists. 
  • Second opinions.
  • Patients who choose multidisciplinary treatment types like chemoradiation, neoadjuvant or preoperative treatment, or a multidisciplinary therapy which includes treatment with cancer drugs (in the case of, for example, breast cancer, ovarian cancer, bladder cancer, stomach cancer).

Special focus

  • Immunotherapy
  • Neoadjuvant treatment methods
  • Cancer drug research and development
  • High dose chemotherapy with stem cell transplant for solid tumors
  • Clinical application of molecular techniques (targeted therapies)

Collaboration with Hematology/oncology department at the AMC

The Netherlands Cancer Institute closely collaborates with the Hematology Department at the Amsterdam UMC in terms of medical care and research for people with hematological malignancies (leukemia, lymphoma, and multiple myeloma also known as Kahler’s disease). The Netherlands Cancer Institute primarily provides support for lymphatic malignancies. We meet every week to discuss patients and cancer studies. Patients with acute leukemia or patients who are eligible for an allogeneic stem cell transplant will be referred to the Amsterdam UMC. Patients with lymphomas in the central nervous system are treated at the Netherlands Cancer Institute.

The Netherlands Cancer Institute has received JACIE accreditation for autologous stem cell transplants.